apalutamide | Cafepharma

J&J gets first-of-its-kind prostate cancer approval

Submitted by admin on Wed, 02/14/2018 - 23:48

Source

Biopharma Dive

Headline

J&J gets first-of-its-kind prostate cancer approval

News Tags

prostate cancer

As CAR-Ts go from candidates to brands, what's the marketing strategy?

Submitted by admin on Tue, 02/13/2018 - 09:01

Source

Medical Marketing and Media

Headline

As CAR-Ts go from candidates to brands, what's the marketing strategy?

News Tags

Juno Therapeutics

Strong data lift profile of J&J's cancer drug apalutamide

Submitted by admin on Tue, 02/06/2018 - 11:45

Source

Biopharma Dive

Headline

Strong data lift profile of J&J's cancer drug apalutamide

News Tags

prostate cancer

With Pfizer in hot pursuit, J&J loses a critical patent fight as it scrambles for a new prostate cancer drug OK

Submitted by admin on Thu, 01/18/2018 - 10:00

Source

Endpoints

Headline

With Pfizer in hot pursuit, J&J loses a critical patent fight as it scrambles f…

News Tags

prostate cancer

The top 10 prospective blockbuster drug launches slated for 2018 — Evaluate

Submitted by admin on Sun, 12/17/2017 - 11:47

Source

Endpoints

Headline

The top 10 prospective blockbuster drug launches slated for 2018 — Evaluate

News Tags

J&J takes another big step forward with next-gen prostate cancer blockbuster apalutamide

Submitted by admin on Thu, 10/12/2017 - 09:16

Source

Endpoints

Headline

J&J takes another big step forward with next-gen prostate cancer blockbuster ap…

News Tags

prostate cancer

These 5 Drugs Could Be Worth $45 Billion -- and They're Not Even on the Market Yet

Submitted by admin on Sun, 07/23/2017 - 11:47

Source

Motley Fool

Headline

These 5 Drugs Could Be Worth $45 Billion -- and They're Not Even on the Market …

News Tags

Subscribe to apalutamide